Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study

PURPOSE: To evaluate the 1-year safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease compared with placebo. METHODS: SONATA (Safety Of a 5.0% coNcentrATion of lifitegrAst ophthalmic solution) was a multicenter, randomized, prospective, double-masked, placebo-controlled pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Donnenfeld, Eric D., Karpecki, Paul M., Majmudar, Parag A., Nichols, Kelly K., Raychaudhuri, Aparna, Roy, Monica, Semba, Charles P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859202/
https://www.ncbi.nlm.nih.gov/pubmed/27055211
http://dx.doi.org/10.1097/ICO.0000000000000803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859202/
https://www.ncbi.nlm.nih.gov/pubmed/27055211
http://dx.doi.org/10.1097/ICO.0000000000000803

Ejemplares similares